Finance PhD: Move Your Money Before April 30th
The clock just starting ticking on the biggest financial event in 20 years. The next few weeks could decide your wealth in 2021.
See what you should do now

NVC Insider Trading (Neovasc)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$27,581.00
Insider Selling (Last 12 Months): C$0.00

Neovasc Insider Trading History Chart

Neovasc Share Price & Price History

+0.30 (1.20%)
As of 03/10/2017 08:06 PM ET
Days: 30 | 90 | 365
Get out of cash NOW
Millionaire Wall Street Legend Urges Americans To Get Out Of CASH before April 27th.
Details here.

Neovasc Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2021Paul GeyerDirectorBuy25,000C$1.09C$27,245.0098,333
6/12/2020Doug JanzenDirectorBuy100C$3.36C$336.00121,638
7/3/2019Paul GeyerDirectorSell5,357C$1.85C$9,910.45450
11/21/2018Paul GeyerDirectorSell5,343C$1.88C$10,025.50
See Full Table
Neovasc logo
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Read More

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A


46,869 shs

Average Volume

111,876 shs

Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Neovasc?

Neovasc's top insider investors include:
  1. Doug Janzen (Director)
  2. Paul Geyer (Director)
Insider Urges: Get Out Of Cash Before April 27th
Chris Rowe says there’s a huge stock market event looming - and he’s revealing his #1 pick for free.
Click here to find out more.